je.st
news
Tag: analysts
Investment Analysts' Downgrades for November, 28th (ACT, AUE,...
2013-11-29 11:35:04| Biotech - Topix.net
They currently have $172.00 price target on the stock. Zacks' analyst wrote, "Actavis' third quarter EPS of $2.09 was a penny short of the Zacks Consensus Estimate but up 55% y/y.
Tags: november
act
investment
28th
Analysts' Ratings Reiterations for November, 28th (AFR, ANF,...
2013-11-29 04:45:40| Apparel - Topix.net
Investec currently has a GBX 170 price target on the stock. had its underperform rating reaffirmed by analysts at Zacks.
Tags: november
ratings
28th
analysts
Repros Therapeutics: Small Biotech Play Analysts Believe Can Double
2013-11-28 18:36:35| Biotech - Topix.net
Regular readers of my columns know that when it comes to investing in the biotech sector I take numerous small positions with a lot of promising but speculative small cap plays.
Tags: small
play
double
analysts
Galena Biopharma Receives New Coverage from Analysts at Oppenheimer
2013-11-27 00:45:43| Biotech - Topix.net
The firm set an "outperform" rating and a $6.00 price target on the stock. Oppenheimer's price target suggests a potential upside of 63.49% from the stock's previous close.
Tags: coverage
receives
analysts
oppenheimer
Medidata Solutions Price Target Increased to $16.00 by Analysts at B. Riley
2013-11-26 22:56:05| IT Services - Topix.net
The firm currently has a "neutral" rating on the stock. B. Riley's price target would indicate a potential downside of 86.69% from the stock's previous close.
Tags: price
solutions
increased
target
Sites : [492] [493] [494] [495] [496] [497] [498] [499] [500] [501] [502] [503] [504] [505] [506] [507] [508] [509] [510] [511] next »